Treatment of mild to moderate Graves' ophthalmopathy with sodium diclofenac: a pilot study.
نویسندگان
چکیده
OBJECTIVE To report the use of sodium diclofenac, an antagonist of PPAR-gamma and cyclooxigenase-2 (COX-2) inhibitor in the treatment of mild to moderate Graves' ophthalmopathy. SUBJECTS AND METHODS Thirteen patients with clinical activity score (CAS) 2 to 7 were treated during a period ranging from 3 to 12 months (mean 7.8 ± 3.4) with oral sodium diclofenac, 50 mg every 12 hours. RESULTS Extra-ocular muscle restriction and CAS improved significantly, p = 0.003 and = 0.004, respectively. Ocular pain and diplopia disappeared, except for one patient who reported improvement of these symptoms. No recurrence was found after interruption of treatment. CONCLUSIONS Treatment of moderate Graves' ophthalmopathy with oral sodium diclofenac is a good, safe and less expensive therapeutic option. Like others new treatment trials, findings must be confirmed in a greater number of patients in a controlled study.
منابع مشابه
Psychological disturbance in graves ophthalmopathy.
OBJECTIVE To study mood disturbance in Graves ophthalmopathy. METHODS Forty-eight patients (mean age, 55 years; 40 women and 8 men) with Graves ophthalmopathy from a university-based referral center were classified into two groups, 24 with moderate/severe disease (study group) and 24 with negligible/mild disease (control group). The groups were matched with regard to demographic and medical c...
متن کامل[Inactive Graves' ophthalmopathy and self-esteem].
PURPOSE To assess the self-esteem of Graves' ophthalmopathy patients in the inactive phase. METHODS Thirty euthyroid patients were evaluated in the inactive phase of disease with age ranging from 26 to 65 years, average of 43 +/- 11,0 years, called study group and 39 individuals without Graves' ophthalmopathy with age ranging from 18 to 67 years, average of 41 +/- 13,4 years, selected from th...
متن کاملA Single Center Experience of Intravenous Corticosteroid Bolus Doses in Graves’ Ophthalmopathy
Exophthalmos makes up a clinical manifestation very frequent in Graves’ disease. European Group on Graves’ Orbitopathy proposes intravenous glucocorticoids to treat severe, moderate-to-severe and active Graves’ orbitopathy as the first line treatment. The aim of our study is to report results obtained with patients treated for Graves’ ophthalmopathy with this protocol in real life. It is a desc...
متن کاملEfficacy and safety of radioiodine therapy for mild Graves ophthalmopathy depending on cigarette consumption: a 6‑month follow‑up.
INTRODUCTION Graves ophthalmopathy (GO) is an autoimmune disease associated with Graves disease. Its treatment is largely dependent on the severity and activity of ocular lesions. Particular attention should be given to radioiodine (RAI) therapy. Although its use is a valuable therapeutic option for hyperthyroidism, it may be followed by worsening of GO. OBJECTIVES The aim of the present...
متن کاملDiagnosis, Follow-Up and Treatment Results in Thyroid Ophthalmopathy
OBJECTIVES To discuss our follow-up and treatment results in thyroid-associated ophthalmopathy (TAO). MATERIALS AND METHODS The records of 168 TAO cases who were followed at our clinic between October 1998 and October 2013 were reviewed retrospectively. The severity and activity of the disease were evaluated according to the criteria of the European Group on Graves' Ophthalmopathy (EUGOGO...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Arquivos brasileiros de endocrinologia e metabologia
دوره 55 9 شماره
صفحات -
تاریخ انتشار 2011